Vasoactive intestinal peptide tumors (VIPoma) are neuroendocrine tumors secreting vasoactive intestinal peptide (VIP) in an unregulated manner. Werner and Morrison first described them in 1958 as a pancreatic tumor resulting in watery diarrhea and hypokalemia . In 1973, the team of Bloom, Polak, and Pearse confirmed that the mediator was VIP . The VIPoma syndrome is also known as Verner-Morrison syndrome, watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria (WDHA) syndrome, and pancreatic cholera syndrome . This review highlights the clinical presentation, diagnosis, and management.
Copyright © 2024, StatPearls Publishing LLC.